MedBlog

Trials assess novel nanoparticle’s impact on brain cancer patients

Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. Neurosurgeon Toral Patel, M.D., and Neuro-Oncologist Michael Youssef, M.D., discuss how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.

Toral Patel, M.D. / Michael Youssef, M.D.

July 12, 2024

DARTBOARD: Novel head & neck cancer trial targets personalized, daily radiation therapy

David Sher, M.D. explains how a new clinical trial for head and neck cancer patients will study daily adaptive radiotherapy using tumor targeting driven by an AI-driven algorithm developed by UT Southwestern.

David Sher, M.D.

March 2, 2022

Coming of age with cancer: ACE helps young survivors thrive

Daniel Bowers, M.D., Medical Director of the After the Cancer Experience program, discusses the importance of lifelong care for childhood cancer survivors.

Daniel Bowers, M.D.

February 9, 2022

Multiple myeloma care: Taking CAR T-cell therapy for rare blood cancer to the next level

As new CAR T-cell therapies are being approved to treat certain cancers, Ankit Kansagra, M.D., explains how the UT Southwestern team is working to further revolutionize treatment for more cancer patients.

December 1, 2021